The efficacy of non-sreroidal anti-inflammatory drugs

Close metadata

Recommended articles:

Patients with ischaemic heart disease and non-steroidal anti-inflammatory drugs dosing — recommendations and real-life clinical setting. Russian Journal of Preventive Medicine. 2024;(6):68-73

Efficacy and safety of metamizole sodium for pain syndrome in adults and children: a systematic review. Russian Journal of Pain. 2024;(4):65-80

Use of a fixed combination of diclofenac and orphenadrine (Neodolpasse) for postoperative analgesia after extended gastrectomy with resection of the lower third of the esophagus. P.A. Herzen Journal of Oncology. 2025;(2):52-56

The paper presents current views on the efficacy of nonsteroidal anti-inflammatory drugs (NSAID). The authors analyze strengths and weaknesses of modern approaches and trends in the use of NSAID and highlight promising directions for clinical research of NSAIDs’ efficacy.

Keywords:

NSAIDs

on-demand NSAIDs intake

continuous NSAIDs administration

de-escalation of NSAIDs

efficacy of NSAIDs

Authors:

Gaydukova I.Z.

Mechnikov North-West State Medical University, St. Petersburg, Russia

Mazurov V.I.

North-Western State Medical University named after I.I. Mechnikov, St.-Petersburg, Russia

List of references:

Karateev AE, Nasonov EL, Ivashkin VT, Martynov AI, Yakhno NN, Arutyunov GP, Alekseeva LI, Abuzarova GR, Evseev MA, Kukushkin ML, Kopenkin SS, Lila AM, Lapina TL, Novikova DS, Popkova TV, Rebrov AP, Skorobogatykh KV, Chichasova NV; Association of Rheumatologists of Russia, Russian Society for the Study of Pain, Russian Gastroenterology Association, Russian Scientific Medical Society of Therapists, Association of Traumatologists and Orthopedists of Russia, Russian Association of Palliative Medicine. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2018;56(1):1-29. (In Russ.) https://doi.org/10.14412/1995-4484-2018-1-29
Mazurov VI, Trofimov EA, Lesnyak OM, Belyaeva IB. Rheumatology. Pharmacotherapy without errors. A guide for doctors. By ed. Mazurov V.I., Lesnyak O.M. M.: E-noto; 2017. (In Russ.)
van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991. https://doi.org/10.1136/annrheumdis-2016-210770
Steinmeyer J, Bock F, Stöve J, Jerosch J, Flechtenmacher J. Pharmacological treatment of knee osteoarthritis: Special considerations of the new German guideline. Orthop Rev (Pavia). 2018;10(4):7782. eCollection 2018 Dec 6. https://doi.org/10.4081/or.2018.7782
da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2016;387:2093-2105. https://doi.org/10.1016/S0140-6736(17)31744-0
European Medicines Evaluation Agency (EMEA): Public assessment report for medicinal products containing non-selective non steroidal antiinflammatory drugs (NSAIDs). Published on 07/11/2006. Accessed on 20.03.2018. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2010/01/WC500054344.pdf
Schoels MM, Braun J, Dougados M, Emery P, Fitzgerald O, Kavanaugh A, Kvien TK, Landewé R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Sieper J, Smolen JS, Wit Md, van der Heijde D. Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann Rheum Dis. 2014;73(1):238-242. https://doi.org/10.1136/annrheumdis-2013-203860
Wendling D. Treating to target in axial spondyloarthritis: defining the target and the arrow. Expert Rev Clin Immunol. 2015;11(6):691-693. https://doi.org/10.1586/1744666X.2015.1039514
Gaidukova IZ, Rebrov AP, Otteva EN, Badokin VV, Bochkova AG, Bugrova OV, Godzenko AA, Dubikov AA, Ivanova ON, Korotaeva TV, Lapshina SA, Nesmeyanova OB, Nikishina I.P., Raskin TA, Rumyantseva TA, Smirnov AV, Sitalo AV, Erdes ShF. Use of nonsteroidal anti-inflammatory drugs for the treatment of axial spondyloarthritis, including ankylosing spondylitis, monitoring their efficacy and safety (draft guidelines of the Expert Spondyloarthritis Diagnosis and Treatment Group). Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(1):67-74. (In Russ.) https://doi.org/10.14412/1995-4484-2016-1S-67-74
Gaidukova IZ, Rebrov AP, Aparkina AV. Efficacy and safety of using nimesulide (Nemulex) in patients with active ankylosing spondylitis who have not achieved remission or low activity with other NSAIDs. RMJ. 2015;23(7):378-381. (In Russ.)
Xu S, Rouzer CA, Marnett LJ. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond. IUBMB Life. 2014;66(12):803-811. Epub 2014 Dec 23. https://doi.org/10.1002/iub.1334
Timmers L, Pasterkamp G, de Kleijn DP. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases? Mol Interv. 2007;7(4):195-199, 180.
Ross WB, Leaver HA, Yap PL, Raab GM, Su BH, Carter DC. Prostaglandin E2 production by rat peritoneal macrophages: role of cellular and humoral factors in vivo in transfusion-associated immunosuppression. FEMS Microbiol Immunol. 1990;2:321-325.
Murakami M, Nakashima K, Kamei D, Masuda S, Ishikawa Y, Ishii T. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem. 2003;278:37937-37947.
Na YR, Yoon YN, Son DI, Seok SH. Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model. PLoS One. 2013;8(5):e63451. Published online 2013 May 7. https://doi.org/10.1371/journal.pone.0063451
Kumagai K, Kubo M, Imai S, Toyoda F, Maeda T, Okumura N, Matsuura H, Matsusue Y. The COX-2 Selective Blocker Etodolac Inhibits TNFα-Induced Apoptosis in Isolated Rabbit Articular Chondrocytes. Int J Mol Sci. 2013;14(10):19705-19715. Published online 2013 Sep 30. https://doi.org/10.3390/ijms141019705
Dong X, Li R, Xiu P, Dong X, Xu Z, Zhai B, Liu F, Jiang H, Sun X, Li J, Qiao H. Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways. PLoS One. 2014;9(3):e92864. Published online 2014 Mar 27. https://doi.org/10.1371/journal.pone.0092864
Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J.Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70(8):1369-1374. https://doi.org/10.1136/ard.2010.145995
Wanders A, Heijde Dv, Landewé R, Béhier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52:1756-1765. https://doi.org/10.1002/art.21054
Sim ZH, Pinard CL, Plattner BL, Bienzle D. Cyclooxygenase-2 expression in the eyes of cats with and without uveitis. Am J Vet Res. 2018;79(1):90-97. https://doi.org/10.2460/ajvr.79.1.90
Kern MA, Schubert D, Sahi D, Schöneweiss MM, Moll I, Haugg AM, Dienes HP, Breuhahn K, Schirmacher P. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology. 2002;36:885-894. https://doi.org/10.1053/jhep.2002.36125
Sieper J, Listing J, Poddubnyy D., Song IH, Hermann KG, Callhoff J, Syrbe U, Braun J, Rudwaleit M. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis. 2016;75:1438-1443. [PubMed]. https://doi.org/10.1136/annrheumdis-2015-207897
Wanders A, Heijde Dv, Landewé R, Béhier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52(6):1756-1765. https://doi.org/10.1002/art.21054
Gaydukova IZ, Rebrov AP, Nam IF, Kirsanova NV. Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis. Therapeutic Archive. 2014;86(12):42-47. (In Russ.) https://doi.org/10.17116/terarkh2014861242-47
Gaidukova IZ, Rebrov AP, Lapshina SA, Otteva EN, Dubinina TV, Badokin VV, Bochkova AG, Bugrova OV, Godzenko AA, Dubikov AI, Ivanova ON, Korotaeva TV, Nesmeyanova OB, Nikishina IP, Raskina TA, Rumyantseva OA, Smirnov AV, Sitalo AV, Erdes ShF. Use of nonsteroidal anti-inflammatory drugs and biological agents for the treatment of axial spondyloarthritides. Recommendations of the Spondyloarthritis Study Group of Experts, All-Russian Public Organization «The Association of Rheumatology of Russia». Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(5):474-484. (In Russ.) https://doi.org/10.14412/1995-4484-2017-474-484
Karateev AE, Lila AM, Pogozheva EYu, Amirdzhanova VN. The efficacy of meloxicam in acute back pain: results of an observational non-interventional multicenter study. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2018;118(6):24-30. (In Russ.) https://doi.org/10.17116/jnevro20181186124
Lewis SC, Langman MJS, Laporte JR. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANS AIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Brit J Clin Pharm. 2002;54:320-326.
Gaidukova IZ, Rebrov AP. Efficacy and safety of different prescribing regimens for patients with axial spondyloarthritis, including ankylosing spondylitis. Therapeutic Archive. 2015;87(3):77-82. (In Russ.) https://doi.org/10.17116/terarkh201587377-82
Bichurina DM, Gaydukova IZ, Rebrov AP. Efficacy and renal safety of meloxicam in patients with degenerative-dystrophic diseases of the spine: the results of the scientific program «Moment». Bulletin of the North-West State Medical University I.I. Mechnikov. 2018;10(4):31-36. (In Russ.)

Close metadata